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Conclusions: Bending and lifting activities caused the most
pain and resulted in reduced activity. Patients participated and
experienced pain in activities that surgeons do not recommend.
Some recommended activities such as walking and stair climbing
caused pain. The pain pattern during activity over time appears
to differ between TKR and THR patients. This is one of the ﬁrst
studies to quantify activity levels and show a relation between
activities and pain in THR and TKR patients. Further research is
needed to explore differences between THR and TKR patients
and to establish the relations among activity, pain and need for
revision surgery.
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Purpose: To evaluate the efﬁcacy and safety of extended-release
hydrocodone/acetaminophen (HC/APAP CR) tablet (15/500 mg)
for the management of moderate to severe osteoarthritis (OA)
pain.
Methods: This Phase 2, randomized, multicenter, double-blind,
placebo-controlled study comprised 5 periods: 3-week screen-
ing/washout, 1-week titration (1 tablet twice daily), 3-week main-
tenance (2 tablets twice daily), 1-week study drug taper (1 tablet
twice daily), 1-week Follow-Up. The primary efﬁcacy endpoint
was change in patient assessment of OA pain by visual analog
scale (VAS) (0-100 mm) from baseline to ﬁnal evaluation at the
end of the maintenance period.
Results: 120 patients received at least 1 dose of study drug
and were the intent-to-treat dataset (n=58 HC/APAP CR, n=62
placebo). Most patients were white (79%) and female (72%) with
a mean age of 57 years; no statistically signiﬁcant differences
were found between the treatment groups in regard to any demo-
graphic variable. The mean decrease in VAS score from baseline
to ﬁnal visit was 38.5 mm in HC/APAP CR patients versus 26.7
mm in placebo patients (p=0.033). The mean percent decrease
in VAS scores from baseline to ﬁnal visit was 52.5% in HC/APAP
CR compared with 36.0% in placebo (p=0.027). Overall incidence
of adverse events was higher in patients receiving HC/APAP CR
compared with placebo (p≤0.05). The most common adverse
events reported in patients were nausea (21%), constipation
(17%), somnolence (19%), pruritus (12%), and vomiting (10%).
Conclusions: The HC/APAP CR group showed clinically and
statistically signiﬁcant reductions in VAS pain scores compared
with placebo. The safety data demonstrated an AE proﬁle consis-
tent with that of a mu-opioid receptor agonist-containing agent.
Twice-daily dosing of HC/APAP CR tablets may provide an im-
portant and more convenient treatment alternative for patients
with moderate to severe chronic OA pain.
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COMPARISON OF PROPRIOCEPTIVE FUNCTIONS
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Purpose: The aim of this study was to compare proprioceptive
function, pain, isokinetic muscle function and walking ability be-
tween functional squat system proprioceptive facilitation exercise
(FSPFE) and closed kinetic chain exercise (CKCE) in patients
with knee osteoarthritis.
Methods: Forty patients with bilateral knee osteoarthritis
were randomly assigned to FSPFE (mean age=48.78 ± 8.46
years,body mass index=26.2 ± 2,81) and CKCE groups (mean
age=53.8 ± 6.33 years,body mass index=28.5 ± 5.56). Both ex-
ercise groups underwent a 4-week program of ﬁve sessions per
week. The FSPFE program included proprioceptive exercises.
CKCE included lunge exercise, mini-squat exercise, Thera-band
exercises for strengthening the pelvic region and isometric exer-
cises in different knee angles for 3 sets of 10 repetitions. Main
outcome measures included isokinetic strength of knee exten-
sors and ﬂexors (ISOMED 2000), physical functioning (Timed
“Up & Go” Test (TUG)) and proprioception test by using Func-
tional Squat System, self-reported questionnaire (WOMAC- the
Western Ontario and McMaster Universities Osteoarthritis Index)
and visual analogue scale (VAS) for he intensity of pain during
activity, at rest and night. All tests were done before and after
the 4-week treatment period.
Results: WOMAC, TUG and proprioception tests results of
CKCE group were; t=5.2, t=5.5 and t=1.02, respectively (p<0.05).
VAS scores during rest, at activity and night for left knee; t=3.3,
t=9.2, t=4 and for right knee; t=2.2, t=6.14, t=3, respectively
(p<0.05). Results of FSPFE group in WOMAC, TUG and proprio-
ception tests were; t=4.6, t=7.8 and t=-3.4, respectively (p<0.05).
VAS scores during rest, at activity and night for left knee; t=3.3,
t=8.5, t=2.4 and for right knee; t=3.3, t=6.4, t=2.6, respectively
(p<0.05). And also signiﬁcant improvements were seen in isoki-
netic strength in both groups (p<0.05). FSPFE group showed
greater improvement in VAS scores during activity and propri-
ception test (p<0.05).
Conclusions: The results of this study showed that both FSPFE
and CKCE were effective in improving joint position sense and
also function, muscle strength and pain. The increase in propri-
oception ability in CKCE patients was not as great as that seen
in FSPFE patients.
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Purpose: To correlate the clinical features and functional status
with the distribution of abnormalities and severity of radiographic
changes in patients with knee OA.
Methods: We studied a group of patients with knee OA (ACR
criteria) from a rheumatology department in Galicia, Spain. A
questionnaire including epidemiologic data, physical examina-
tion, anthropometric measurements, functional status and quality
of life was performed. Radiographic damage was categorized
